Suchergebnisse - "Rahman, Omar"

PubPharm (12)

1

Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors : a systematic review and meta-analysis

enthalten in: Breast cancer (Tokyo, Japan) | 2018

von Kassem, L. | Shohdy, K. | Lasheen, S. | +2

2

Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors : a systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2017

von Lasheen, S. | Shohdy, K. | Kassem, L. | +1

3

Development of sorafenib-related side effects in patients diagnosed with advanced hepatocellular carcinoma treated with sorafenib : a systematic-review and meta-analysis of the impact on survival

enthalten in: Expert review of gastroenterology & hepatology | 2017

von Abdel-Rahman, O. | Lamarca, A.

4

Risk of selected gastrointestinal toxicities in patients with advanced non-small cell lung cancer receiving erlotinib : a systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2015

von Abdel-Rahman, O. | Fouad, M.

5

Risk of fatigue in patients with solid tumors treated with everolimus, temsirolimus or ridaforolimus : a comparative meta-analysis

enthalten in: Expert review of anticancer therapy | 2015

von Abdel-Rahman, O. | Fouad, M.

6

Risk of fatigue and hepatic and metabolic toxicities in patients with solid tumors treated with everolimus : a meta-analysis

enthalten in: Future oncology (London, England) | 2015

von Abdel-Rahman, O. | Fouad, M.

7

Risk of selected gastrointestinal toxicities in cancer patients treated with MEK inhibitors : a comparative systematic review and meta-analysis

enthalten in: Expert review of gastroenterology & hepatology | 2015

von Abdel-Rahman, O. | ElHalawani, H. | Ahmed, H. | +1

8

Risk of selected dermatological toxicities in cancer patients treated with MEK inhibitors : a comparative systematic review and meta-analysis

enthalten in: Future oncology (London, England) | 2015

von Abdel-Rahman, O. | ElHalawani, H. | Ahmed, H.

9

Risk of fatal pulmonary events in patients with advanced non-small-cell lung cancer treated with EGF receptor tyrosine kinase inhibitors : a comparative meta-analysis

enthalten in: Future oncology (London, England) | 2015

von Abdel-Rahman, O. | Elhalawani, H.

10

Risk of cardiovascular toxicities in patients with solid tumors treated with sunitinib, axitinib, cediranib or regorafenib : an updated systematic review and comparative meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2014

von Abdel-Rahman, O. | Fouad, M.